Sona Nanotech Inc.

SONA

CA83541C1059

Medical Equipment, Supplies & Distribution

Market Closed - Canadian Securities Exchange Other stock markets 20:59:59 31/05/2024 BST			5-day change	1st Jan Change
0.35 ^CAD	+14.75%		+9.38%	+45.83%

05-21	Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent	MT
05-21	Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio Md, Msc., Frcsc as Chief Medical Officer	CI

Stockport Exploration, Inc will Change its Name to Sona Nanotech Inc

October 05, 2018 at 05:00 am

Effective October 05, 2018, Stockport Exploration, Inc will change its name to Sona Nanotech Inc.

Latest news about Sona Nanotech Inc.

Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent	05-21	MT
Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio Md, Msc., Frcsc as Chief Medical Officer	05-20	CI
Sona Nanotech Inc. Files Provisional Conjugation Patent	05-20	CI
Sona Nanotech Inc. Announces Further Results from the Triple Negative Breast Cancer Mice Model Portion of Its Current Research Study At Dalhousie University	04-29	CI
Sona Nanotech Provides Interim Results of Dalhousie Study	04-12	MT
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study	04-12	CI
Sona Nanotech Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-29	CI
Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio to its Advisory Board	03-18	CI
Sona Nanotech Inc. Announces Filing of Provisional Patent Application	03-18	CI
Sona Nanotech Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	02-27	CI
Sona Nanotech Inc. Announces Retirement of Michael Gross from the Board of Directors	01-10	CI
Sona Nanotech Inc. announced that it has received CAD 0.75 million in funding	11-26	CI
Sona Nanotech Inc. announced that it has received CAD 0.75 million in funding	11-26	CI
Sona Nanotech Inc. announced that it expects to receive CAD 0.75 million in funding	17/10/23	CI
Sona Nanotech Inc. announced that it expects to receive CAD 0.75 million in funding	17/10/23	CI
Sona Nanotech Inc. Provides Corporate Update on Operating Activities	12/10/23	CI
Sona Nanotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	28/09/23	CI
Sona Nanotech Inc. Announces Innovative Research Initiative to Undertake with Giacomantonio Immuno-Oncology Research Group	11/09/23	CI
Sona Nanotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	28/06/23	CI
Sona Nanotech Inc. Announces First Territorial Patent Grant for Its Proprietary, Toxin-Free Gold Nanorod Manufacturing Process with A Registration in South Korea	18/05/23	CI
Sona Nanotech Inc. Announces Board Changes	18/05/23	CI
Sona Nanotech Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	30/03/23	CI
Sona Nanotech Inc. completed the acquisition of Siva Therapeutics Inc.	22/03/23	CI
Sona Nanotech Inc. Auditor Raises 'Going Concern' Doubt	26/02/23	CI
Sona Nanotech Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	26/02/23	CI

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

Sector

Medical Equipment, Supplies & Distribution

Calendar

24/06/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SONA NANOTECH INC.	+45.83%	22.13M
ABBOTT LABORATORIES	-7.16%	177B
BECTON, DICKINSON AND COMPANY	-4.86%	65.54B
DEXCOM, INC.	-4.28%	47.09B
CENCORA, INC.	+10.32%	43.43B
HOYA CORPORATION	+8.14%	41.77B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.76%	29.55B
TERUMO CORPORATION	+15.53%	24.83B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	23.97B
ZIMMER BIOMET HOLDINGS, INC.	-5.38%	23.54B